Tumor grade not only serves as a prognostic factor but may also serve as a predictive factor for the selection of GEP‐NEN patients for chemotherapy treatment,34 particularly in cases with a well‐differentiated morphology despite a high Ki67 index (>55%).38 This evidence concerns the gene MKI67 and neoplasm.